Nektar Therapeutics (NKTR) Research & Development (2016 - 2025)
Historic Research & Development for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to $27.3 million.
- Nektar Therapeutics' Research & Development fell 2220.6% to $27.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $116.4 million, marking a year-over-year decrease of 470.25%. This contributed to the annual value of $120.9 million for FY2024, which is 590.91% up from last year.
- Per Nektar Therapeutics' latest filing, its Research & Development stood at $27.3 million for Q3 2025, which was down 2220.6% from $29.9 million recorded in Q2 2025.
- Nektar Therapeutics' 5-year Research & Development high stood at $107.3 million for Q1 2022, and its period low was $24.1 million during Q3 2023.
- For the 5-year period, Nektar Therapeutics' Research & Development averaged around $49.5 million, with its median value being $30.5 million (2025).
- In the last 5 years, Nektar Therapeutics' Research & Development plummeted by 7159.15% in 2023 and then skyrocketed by 4553.8% in 2024.
- Quarter analysis of 5 years shows Nektar Therapeutics' Research & Development stood at $99.6 million in 2021, then crashed by 65.13% to $34.7 million in 2022, then decreased by 13.81% to $29.9 million in 2023, then dropped by 4.0% to $28.7 million in 2024, then dropped by 5.19% to $27.3 million in 2025.
- Its Research & Development stands at $27.3 million for Q3 2025, versus $29.9 million for Q2 2025 and $30.5 million for Q1 2025.